| GSK 343 |
GSK343 |
1346704-33-3 |
| Inarigivir (ORI-9020, SB-9000) |
SB9000 |
475650-36-3 |
| CC-92480 |
CC-92480 |
2259648-80-9 |
| Dynarrestin |
Dynarrestin |
2222768-84-3 |
| THAL-SNS-032 |
THAL-SNS-032 |
2139287-33-3 |
| SP2509 |
无中文名称 |
1423715-09-6 |
| Enasidenib |
恩西地平 |
1446502-11-9 |
| ARV-771 |
ARV-771 |
1949837-12-0 |
| Ozanimod |
奥扎莫德 |
1306760-87-1 |
| LOXO-292 |
塞卡替尼 |
2152628-33-4 |
| RG120 |
艾伏尼布 |
1448347-49-6 |
| CYC-065 |
CYC-065 |
1070790-89-4 |
| Seclidemstat |
SECLIDEMSTAT |
1423715-37-0 |
| (S)-2-(6-bromobenzo[d][1,3]dioxol-5-yl)-N-(4-cyanophenyl)-1-(1-cyclohexylethyl)-1H-benzo[d]imidazole-5-carboxamide |
(S)-2-(6-溴苯并[D][1,3]二氧杂环戊烯-5-基)-N-(4-氰基苯基)-1-(1-环己基乙基)-1H-苯并[D]咪唑-5-甲酰胺 |
2100284-59-9 |
| 2-(2-Chlorophenyl)-4-(3-(diMethylaMino)phenyl)-5-Methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione |
2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮 |
1218942-37-0 |
| LY-2584702 (tosylate salt) |
LY2584702 TOSYLATE |
1082949-68-5 |
| GSK-2256098 |
GSK-2256098 |
1224887-10-8 |
| TP 235 |
CPD1598 |
443104-02-7 |
| (2R,3R,4S,5R)-2-(6-aMino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]iMidazol-2-yl)ethyl)cyclobutyl)(isopropyl)aMino)Methyl)tetrahydrofuran-3,4-diol |
(2R,3R,4S,5R)-2-(6-氨基-9H-嘌呤-9-基)-5-((((1R,3S)-3-(2-(6-(叔丁基)-1H-苯并[D]咪唑-2-基)乙基)环丁基)(异丙基)氨基)甲基)四氢呋喃-3,4-二醇 |
1380288-87-8 |
| RDEA119 |
瑞法替尼 |
923032-37-5 |
QQ
微信
